The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Fabrice Barlesi

Department of Thoracic Oncology

Université de la Méditerranée-Assistance Publique Hôpitaux de Marseille

Marseille

France

[email]@*.ap-hm.fr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Thoracic Oncology, Université de la Méditerranée-Assistance Publique Hôpitaux de Marseille, Marseille, France. 2003 - 2010
  • Faculty of Medicine (Université de la Méditerranée), Assistance Publique Hôpitaux de Marseille, Department of Thoracic Oncology, Hôpital Sainte-Marguerite, France. 2004 - 2009

References

  1. Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors. Barlési, F., Balleyguier, C., Besse, B., Bonodeau, F., Brenac, F., Corneloup, O., Dansin, E., Ferretti, G., Gaubert, J.Y., Gervais, R., Lacombe, C., Loundou, A., Moro-Sibilot, D., Planchard, D., Scherpereel, A., Menu, Y. Ann. Oncol. (2010) [Pubmed]
  2. Non-small cell lung cancer-smokers or non-smokers, does it matter? Barlési, F., Nanni-Metellus, I., Breen, D., Fina, F., Astoul, P., Martin, P.M. Lung. Cancer (2009) [Pubmed]
  3. Impact of information on quality of life and satisfaction of non-small cell lung cancer patients: a randomized study of standardized versus individualized information before thoracic surgery. Barlési, F., Barrau, K., Loundou, A., Doddoli, C., Simeoni, M.C., Auquier, P., Thomas, P. J. Thorac. Oncol (2008) [Pubmed]
  4. Second-line treatment for advanced non-small cell lung cancer: a systematic review. Barlési, F., Jacot, W., Astoul, P., Pujol, J.L. Lung. Cancer (2006) [Pubmed]
  5. Preoperative psychological global well being index (PGWBI) predicts postoperative quality of life for patients with non-small cell lung cancer managed with thoracic surgery. Barlési, F., Doddoli, C., Loundou, A., Pillet, E., Thomas, P., Auquier, P. Eur. J. Cardiothorac. Surg (2006) [Pubmed]
  6. Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis. Barlési, F., Tummino, C., Tasei, A.M., Astoul, P. Lung. Cancer (2006) [Pubmed]
  7. CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy. Barlési, F., Tchouhadjian, C., Doddoli, C., Torre, J.P., Astoul, P., Kleisbauer, J.P. Br. J. Cancer (2005) [Pubmed]
  8. Multiple pulmonary nodules and underlying head and neck cancer. Barlesi, F., Gimenez, C., Doddoli, C., Chetaille, B., Guelfucci, B., Kleisbauer, J.P., Thomas, P. Ann. Thorac. Surg. (2005) [Pubmed]
  9. Gefitinib (ZD1839, Iressa) in non-small-cell lung cancer: a review of clinical trials from a daily practice perspective. Barlési, F., Tchouhadjian, C., Doddoli, C., Villani, P., Greillier, L., Kleisbauer, J.P., Thomas, P., Astoul, P. Fundam. Clin. Pharmacol (2005) [Pubmed]
  10. Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung. Barlési, F., Pinot, D., Legoffic, A., Doddoli, C., Chetaille, B., Torre, J.P., Astoul, P. Br. J. Cancer (2005) [Pubmed]
  11. Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy. Barlési, F., Doddoli, C., Torre, J.P., Giudicelli, R., Fuentes, P., Thomas, P., Astoul, P. Eur. J. Cardiothorac. Surg (2005) [Pubmed]
  12. The place of patient satisfaction in quality assessment of lung cancer thoracic surgery. Barlési, F., Boyer, L., Doddoli, C., Antoniotti, S., Thomas, P., Auquier, P. Chest (2005) [Pubmed]
  13. Gemcitabine-induced severe pulmonary toxicity. Barlési, F., Villani, P., Doddoli, C., Gimenez, C., Kleisbauer, J.P. Fundam. Clin. Pharmacol (2004) [Pubmed]
  14. Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer. Barlési, F., Gimenez, C., Torre, J.P., Doddoli, C., Mancini, J., Greillier, L., Roux, F., Kleisbauer, J.P. Respir. Med (2004) [Pubmed]
  15. Bronchioloalveolar carcinoma: myths and realities in the surgical management. Barlesi, F., Doddoli, C., Gimenez, C., Chetaille, B., Giudicelli, R., Fuentes, P., Kleisbauer, J.P., Thomas, P. Eur. J. Cardiothorac. Surg (2003) [Pubmed]
  16. Survival and postoperative complication in daily practice after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer. Barlési, F., Doddoli, C., Chetaille, B., Torre, J.P., Giudicelli, R., Thomas, P., Kleisbauer, J.P., Fuentes, P. Interact. Cardiovasc. Thorac. Surg (2003) [Pubmed]
 
WikiGenes - Universities